<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34425627</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-4413</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>17</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Deutsche medizinische Wochenschrift (1946)</Title><ISOAbbreviation>Dtsch Med Wochenschr</ISOAbbreviation></Journal><ArticleTitle>[Complaints and clinical findings six months after COVID-19: outpatient follow-up at the University Medical Center Freiburg].</ArticleTitle><Pagination><StartPage>e65</StartPage><EndPage>e73</EndPage><MedlinePgn>e65-e73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/a-1546-4291</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">&#x2002;Increasing evidence suggests that some patients suffer from persistent symptoms for months after recovery from acute COVID-19. However, the clinical phenotype and its pathogenesis remain unclear. We here present data on complaints and results of a diagnostic workup of patients presenting to the post-COVID clinic at the University Medical Center Freiburg.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">&#x2002;Retrospective data analysis of persistently symptomatic patients presenting to our clinic at least 6 months after onset of acute COVID-19. All patients were assessed by a doctor and routine laboratory analysis was carried out. Quality of life was assessed using SF-36 questionnaire. In case of specific persisting symptoms, further organ-specific diagnostic evaluation was performed, and patients were referred to respective departments/specialists.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">&#x2002;132 Patients (58 male, 74 female; mean age 53.8&#xa0;years) presented to our clinic at least 6 months after COVID-19. 79 (60&#x200a;%) had been treated as outpatients and 53 (40&#x200a;%) as inpatients. Most common complaints were persistent fatigue (82&#x200a;%) and dyspnea on exertion (61&#x200a;%). Further common complaints were impairments of concentration (54&#x200a;%), insomnia (43&#x200a;%), and impairments of smell or taste (35&#x200a;%). Quality of life was reduced in all sections of the SF-36 questionnaire, yielding a reduced working capacity. Significant pathological findings in laboratory, echocardiographic and radiological work-up were rare. Impairments in lung function tests were more common in previously hospitalized patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">&#x2002;Patients presenting 6 months after onset of acute COVID-19 suffer from a diverse spectrum of symptoms with impaired quality of life, also referred to as Long COVID or Post-Acute Sequelae of SARS-CoV-2 infection (PASC). Further research is needed to determine the frequency of these post-COVID syndromes and their pathogenesis, natural course and treatment options. Evaluation and management should be multi-disciplinary.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>August</LastName><ForeName>Dietrich</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Stete</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilger</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;tz</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biever</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin III - Medizinische Intensivmedizin, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosp</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Neurologie und Neurophysiologie, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;hler</LastName><ForeName>Thomas Christian</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Pneumologie, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerstacker</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Hals-Nasen-Ohrenheilkunde, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seufert</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laubner</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kern</LastName><ForeName>Winfried</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rieg</LastName><ForeName>Siegbert</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin II, Universit&#xe4;tsklinikum Freiburg, Medizinische Fakult&#xe4;t, Albert-Ludwigs-Universit&#xe4;t Freiburg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Persistierende Beschwerden 6 Monate nach COVID-19 &#x2013; Erfahrungen aus der COVID-19-Nachsorgeambulanz des Universit&#xe4;tsklinikums Freiburg.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dtsch Med Wochenschr</MedlineTA><NlmUniqueID>0006723</NlmUniqueID><ISSNLinking>0012-0472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007319" MajorTopicYN="N">Sleep Initiation and Maintenance Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013651" MajorTopicYN="N">Taste Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="HINTERGRUND" NlmCategory="UNASSIGNED">&#x2002;Fortbestehende Beschwerden und &#xe4;rztlich validierte Diagnosen nach COVID-19 sind bislang nicht gut definiert. Wir berichten &#xfc;ber Symptome und Diagnostik bei Patienten in unserer COVID-19-Nachsorgeambulanz.</AbstractText><AbstractText Label="METHODEN" NlmCategory="METHODS">&#x2002;Es erfolgte eine retrospektive Analyse der Beschwerden und Befunde bei erwachsenen Patienten nach labordiagnostisch gesicherter COVID-19-Erkrankung mit &#xfc;ber mindestens 6 Monate fortbestehenden Beschwerden. Neben Anamnese, k&#xf6;rperlicher Untersuchung und Labordiagnostik erfolgte eine symptomgeleitete erweiterte apparative Diagnostik. Die Lebensqualit&#xe4;t wurde mittels SF-36-Fragebogens erfasst.</AbstractText><AbstractText Label="ERGEBNISSE" NlmCategory="UNASSIGNED">&#x2002;132 Patienten mit &#xfc;ber mindestens 6 Monate persistierenden Beschwerden wurden in die Auswertung eingeschlossen (58 m&#xe4;nnlich, 74 weiblich; mittleres Alter 53,8 Jahre). 40&#x200a;% der Patienten waren in der Akutphase station&#xe4;r behandelt worden. Die h&#xe4;ufigsten Beschwerden waren Fatigue (82&#x200a;%), Belastungsdyspnoe (61&#x200a;%), kognitive Beschwerden (54&#x200a;%), Schlafst&#xf6;rungen (43&#x200a;%) und Dysgeusie/-osmie (35&#x200a;%). Die Lebensqualit&#xe4;t war in allen im SF-36 abgefragten Bereichen eingeschr&#xe4;nkt. Immerhin 23&#x200a;% der zuvor Berufst&#xe4;tigen waren aus gesundheitlichen Gr&#xfc;nden f&#xfc;r mindestens 6 Monate arbeitsunf&#xe4;hig. Signifikante Pathologien in der laborchemischen und apparativen Diagnostik waren insbesondere bei ambulant behandelten Patienten dagegen selten; Lungenfunktionsst&#xf6;rungen waren h&#xe4;ufiger bei ehemals station&#xe4;r behandelten Patienten.</AbstractText><AbstractText Label="DISKUSSION/SCHLUSSFOLGERUNGEN" NlmCategory="UNASSIGNED">&#x2002;Patienten nach COVID-19 berichten &#xfc;ber vielf&#xe4;ltige Symptome, f&#xfc;r die h&#xe4;ufig kein organpathologisches Korrelat gefunden werden kann. Dies geht mit Einschr&#xe4;nkungen der Lebensqualit&#xe4;t und Arbeitsf&#xe4;higkeit, auch 6 Monate nach Akutinfektion, einher. Populationsbasierte Pr&#xe4;valenz, Pathogenese, Langzeitverlauf und Therapiem&#xf6;glichkeiten dieses vielfach als Long COVID bezeichneten Syndroms sind weitgehend ungekl&#xe4;rt. Aufgrund der vielf&#xe4;ltigen Beschwerden sollte die Patientenversorgung interdisziplin&#xe4;r erfolgen und vermehrt Leistungsdiagnostik und systematische neuropsychiatrische Tests beinhalten.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></OtherAbstract><CoiStatement>Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>23</Day><Hour>20</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34425627</ArticleId><ArticleId IdType="doi">10.1055/a-1546-4291</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>